| | |
| Thirty-eight feared dead in Russian psychiatric hospital fire Thursday, Apr 25, 2013 08:36 PM PDT MOSCOW (Reuters) - A fire raged through a psychiatric hospital north of Moscow on Friday and 38 people were feared dead, Russian emergency officials and media reports said. There were believed to have been 41 people in the building when the fire broke out - 38 patients and three staff members - and three were evacuated, the Emergency Situations Ministry said. It said emergency workers searching the hospital had found 12 bodies so far and that the fire had been extinguished. A Health Ministry official said 38 people were feared dead, state-run RIA news agency reported. ... Full Story | Top |
| Theravance to split into two listed companies Thursday, Apr 25, 2013 05:14 PM PDT (Reuters) - Biopharmaceutical company Theravance Inc said it plans to split into two publicly traded companies, one of which would independently manage the development of the respiratory drugs it is working on with GlaxoSmithKline Plc. The split plan comes after weeks of speculation that the company could be bought by Glaxo, Theravance's largest shareholder with a stake of about 27 percent. Theravance shares were up about 10 percent at $33.50 in after-hours trading on Thursday. ... Full Story | Top |
| Bidders for Carestream down to Bain, THL: sources Thursday, Apr 25, 2013 03:51 PM PDT By Greg Roumeliotis and Soyoung Kim NEW YORK (Reuters) - The number of potential bidders for Onex Corp's Carestream Health Inc has fallen to two, several people familiar with the matter said, damping hopes of selling the medical imaging company for as much as $3.5 billion. Bain Capital LLC and Thomas H. Lee Partners LP remain in the running, as other private equity firms that were in talks with Onex, including Carlyle Group LP and KKR & Co LP , withdrew from the sale process citing Carestream's uncertain outlook, the people said this week. ... Full Story | Top |
| Shoppers Drug Mart says generic pricing to hit 2013 same-store sales Thursday, Apr 25, 2013 03:43 PM PDT  By Krithika Krishnamurthy (Reuters) - Shoppers Drug Mart Corp, Canada's biggest pharmacy chain, said tightened pricing controls for generic drugs will push its 2013 pharmacy same-store sales outlook to the lower end of its previous guidance. The company had previously forecast pharmacy same-store sales growth of between 1.5 percent to 2.5 percent for 2013. Canada's provinces and territories agreed in January to tighten caps on prices of six widely prescribed generic drugs to cut costs for private and government health programs. ... Full Story | Top |
| Resident doc hours not tied to patient deaths: study Thursday, Apr 25, 2013 02:49 PM PDT By Andrew M. Seaman New York (Reuters Health) - Restricting the number of hours doctors-in-training are allowed to work without rest hasn't led to more patient deaths, according to a new study. Researchers found no increase in deaths over the three years following a rules change that restricted resident doctors to working a maximum of 80 hours per week. In fact, the team reports a decline in deaths during the fourth and fifth years. "This study is nice, because it shows that late after the 2003 changes there seems to be an improvement in mortality," said Dr. ... Full Story | Top |
| Sickle cell disease accounts for many priapism cases Thursday, Apr 25, 2013 02:48 PM PDT By Andrew M. Seaman NEW YORK (Reuters Health) - Thanks to commercials for erectile dysfunction drugs, men know to seek medical attention for "erections lasting more than four hours," but a new study suggests a blood disorder is the cause of many prolonged erections. While the condition - formally known as priapism - is rare, researchers report in The Journal of Urology that between 14 percent and 30 percent of cases that show up in U.S. emergency rooms are men with sickle-cell disease. ... Full Story | Top |
| Pfizer arthritis drug rejected by European regulators Thursday, Apr 25, 2013 02:07 PM PDT  (Reuters) - European regulators declined to approve marketing of Pfizer Inc's new rheumatoid arthritis treatment Xeljanz, citing the risks of the drug compared with its potential benefit, the company said on Thursday. Pfizer said it plans to appeal and "immediately seek a re-examination of the opinion" by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP). Shares of Pfizer, which rose 1 percent to close at $30.26 on the New York Stock Exchange, were down 2.7 percent at $29.45 after hours. ... Full Story | Top |
| Bangladesh building tragedy down to West's cost squeeze: NGOs Thursday, Apr 25, 2013 01:56 PM PDT LONDON (Reuters) - Major western clothing retailers squeezing Asian suppliers and a flawed approach to ensuring even basic working standards are fuelling conditions for tragedies like the latest factory collapse in Bangladesh, NGOs said on Thursday. At least 260 people, mainly female workers, were killed and more than 1,000 were injured when the eight-storey Rana Plaza factory building in Savar, 30 km (20 miles) outside the capital Dhaka, collapsed on Wednesday. ... Full Story | Top |
| Video may help terminal patients make CPR choice Thursday, Apr 25, 2013 11:36 AM PDT By Trevor Stokes NEW YORK (Reuters Health) - Terminally ill cancer patients who watched either of two videos about the option to forego resuscitation overwhelmingly elected that route for the patient in the video, if not for themselves, according to a new study. But the vignettes - whose only difference was whether fictional patients decided on their own to skip cardiopulmonary resuscitation (CPR) or got a recommendation from their doctor - elicited high marks from real patients for the video doctors' compassion in discussing a difficult subject. ... Full Story | Top |
| U.S.-backed HIV vaccine fails; study halted Thursday, Apr 25, 2013 11:09 AM PDT By Julie Steenhuysen CHICAGO (Reuters) - The National Institutes of Health on Thursday halted a study testing an experimental HIV vaccine after an independent review board found the vaccine did not prevent HIV infection and did not reduce the amount of HIV in the blood. The trial, started in 2009, is the latest in a series of failed HIV vaccine trials. The study, called HVTN 505, had enrolled 2,504 volunteers in 19 U.S. cities, and was looking at men who have sex with men and transgender people who have sex with men. ... Full Story | Top |
| Heavy use of herbicide Roundup linked to health dangers: study Thursday, Apr 25, 2013 10:50 AM PDT By Carey Gillam (Reuters) - Heavy use of the world's most popular herbicide, Roundup, could be linked to a range of health problems and diseases, including Parkinson's, infertility and cancers, according to a new study. The peer-reviewed report, published last week in the scientific journal Entropy, said evidence indicates that residues of "glyphosate," the chief ingredient in Roundup weed killer, which is sprayed over millions of acres of crops, has been found in food. ... Full Story | Top |
| Iran says it's ready to resume talks with world powers Thursday, Apr 25, 2013 09:24 AM PDT  By Stephanie Nebehay GENEVA (Reuters) - Iran is ready to resume talks with world powers on its disputed nuclear program and awaits word from the European Union on timing and details, Iran's deputy nuclear negotiator said on Thursday. Ali Bagheri, in an interview with Reuters in Geneva, said Iran needed 20 percent-enriched uranium for its Tehran research reactor and four others being built, and was continuing to convert some of its stockpile into reactor fuel. "We are waiting for Lady Ashton to call Dr. Jalili, and Dr. Jalili is obviously ready to take the call," Bagheri said. ... Full Story | Top |
| New guidelines did not change mammography rates Thursday, Apr 25, 2013 08:53 AM PDT By Genevra Pittman NEW YORK (Reuters Health) - The proportion of women undergoing screening for breast cancer every year did not change after a government-backed panel said women in their 40s shouldn't have routine mammograms, according to a new study. In 2009, the U.S. Preventive Services Task Force (USPSTF) recommended that women aged 50 to 74 have a mammogram every other year and said for younger women, screening should be an individual decision by each woman with her doctor. ... Full Story | Top |
| Shire settles with Actavis, Watson Pharma on ADHD drug Thursday, Apr 25, 2013 06:53 AM PDT (Reuters) - Drugmaker Shire Plc said it settled all litigation with Actavis Inc and Watson Pharma, allowing the two companies to sell a generic version of Shire's drug, Intuniv, to treat attention deficit hyperactivity disorder. The settlement gives Actavis the license to make and sell its version of Intuniv in the United States from December 1, 2014. Actavis will get a 180-day period to exclusively market Intuniv, during which it will have to pay Shire a royalty of 25 percent of gross profits from the sale of the drug. ... Full Story | Top |
| Scientists confirm new H7N9 bird flu has come from chickens Thursday, Apr 25, 2013 06:43 AM PDT  By Kate Kelland LONDON (Reuters) - Chinese scientists have confirmed for the first time that a new strain of bird flu that has killed 23 people in China has been transmitted to humans from chickens. In a study published online in the Lancet medical journal, the scientists echoed previous statements from the World Health Organization (WHO) and Chinese officials that there is as yet no evidence of human-to-human transmission of this virus. The H7N9 strain has infected 109 people in China since it was first detected in March. ... Full Story | Top |
|
No comments:
Post a Comment